Correction to: Novel Trial Design: CHIEF-HF
In the article by Spertus et al, “Novel Trial Design: CHIEF-HF,” which published online on March 16, 2021 and appeared
Read moreIn the article by Spertus et al, “Novel Trial Design: CHIEF-HF,” which published online on March 16, 2021 and appeared
Read moreIn the article by Tamaki et al, “Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in
Read moreCirculation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/14/4″>Volume 14, Issue 4</a>, April 1, 2021. Source link
Read moreCirculation: Heart Failure, Ahead of Print. Background:Carbon monoxide poisoning (COP) is an important public health issue around the world. It
Read moreCarolyn S.P. Lam Correspondence to: Carolyn S.P. Lam, MBBS, PhD, National Heart Centre Singapore, 5 Hospital Dr, Singapore 169609, Email
Read moreCirculation: Heart Failure, Ahead of Print. The health burden of heart failure with preserved ejection fraction is increasingly recognized. Despite
Read moreCirculation: Heart Failure, Ahead of Print. Background:The LATERAL trial validated the safety and efficacy of the thoracotomy approach for implantation
Read moreBackground: The impact of hospital readmission reduction program (HRRP) on heart failure (HF) outcomes has been debated. Limited data exist
Read moreHarlan M. Krumholz Harlan M. Krumholz, MD, SM, Yale New Haven Hospital, 1 Church St, Suite 200, New Haven, CT
Read moreCirculation: Cardiovascular Quality and Outcomes, Ahead of Print. Source link
Read more